Payment overview · 2025
General Payments
$83.91
5 reported records · 3 companies
Healthcare provider profile · identity verified
Steven M Gauze, ARNP
Physician Assistants & Advanced Practice Nursing Providers|Clinical Nurse Specialist|Family Health · INEZ, KY · NPI 1083613079
Verified facts
What the public records show
CMS Open Payments records show Steven M Gauze, ARNP received $83.91 in general payments during 2025 across 5 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 59.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $49.85 | 59.4% | 3 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $17.12 | 20.4% | 1 | 2025 |
| Indivior Inc. | Unresolved — no canonical attribution shown | $16.94 | 20.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $83.91 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49.85 | 3 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $17.12 | 1 | 2025 |
Source payment records
|
|||||
| SUBLOCADE Normalized: sublocade |
Drug | Indivior Inc. | $16.94 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Lisinopril | Lisinopril | 798 | 137 |
| Levothyroxine Sodium | Levothyroxine Sodium | 737 | 117 |
| Omeprazole | Omeprazole | 643 | 115 |
| Atorvastatin Calcium | Atorvastatin Calcium | 642 | 116 |
| Amlodipine Besylate | Amlodipine Besylate | 493 | 83 |
| Hydrochlorothiazide | Hydrochlorothiazide | 474 | 84 |
| Gabapentin | Gabapentin | 472 | 74 |
| Metformin Hcl | Metformin Hcl | 460 | 87 |
| Fluconazole | Fluconazole | 345 | 147 |
| Famotidine | Famotidine | 340 | 67 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 338 | 72 |
| Pantoprazole Sodium | Pantoprazole Sodium | 334 | 67 |
| Ibuprofen | Ibuprofen | 318 | 68 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 290 | 96 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 289 | 53 |
| Furosemide | Furosemide | 288 | 61 |
| Simvastatin | Simvastatin | 283 | 51 |
| Potassium Chloride | Potassium Chloride | 269 | 62 |
| Meloxicam | Meloxicam | 265 | 59 |
| Prednisone | Prednisone | 260 | 154 |
| Azithromycin | Azithromycin | 258 | 179 |
| Escitalopram Oxalate | Escitalopram Oxalate | 246 | 37 |
| Losartan Potassium | Losartan Potassium | 245 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 234 | 48 |
| Ondansetron Odt | Ondansetron | 221 | 63 |
| Metoprolol Tartrate | Metoprolol Tartrate | 211 | 42 |
| Tizanidine Hcl | Tizanidine Hcl | 211 | 43 |
| Metoprolol Succinate | Metoprolol Succinate | 203 | 40 |
| Tramadol Hcl | Tramadol Hcl | 191 | 40 |
| Citalopram Hbr | Citalopram Hydrobromide | 182 | 31 |
| Pregabalin | Pregabalin | 179 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 171 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 159 | 30 |
| Sertraline Hcl | Sertraline Hcl | 154 | 21 |
| Januvia | Sitagliptin Phosphate | 142 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 139 | 100 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 138 | 26 |
| Carvedilol | Carvedilol | 129 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 128 | 24 |
| Cefdinir | Cefdinir | 125 | 94 |
| Atenolol | Atenolol | 124 | 22 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 124 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 123 | 19 |
| Allopurinol | Allopurinol | 118 | 19 |
| Montelukast Sodium | Montelukast Sodium | 118 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 117 | 36 |
| Meclizine Hcl | Meclizine Hcl | 107 | 45 |
| Trazodone Hcl | Trazodone Hcl | 107 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 100 | 21 |
| Ozempic | Semaglutide | 99 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 94 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 90 | 22 |
| Ropinirole Hcl | Ropinirole Hcl | 86 | 13 |
| Mounjaro | Tirzepatide | 84 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 83 | 15 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 80 | 13 |
| Warfarin Sodium | Warfarin Sodium | 80 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 79 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 79 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 76 | 15 |
| Celecoxib | Celecoxib | 75 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 75 | 13 |
| Eliquis | Apixaban | 74 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 71 | 61 |
| Clonazepam | Clonazepam | 69 | 17 |
| Lansoprazole | Lansoprazole | 61 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 61 | 15 |
| Alprazolam | Alprazolam | 60 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 59 | 28 |
| Diazepam | Diazepam | 55 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 55 | 16 |
| Donepezil Hcl | Donepezil Hcl | 54 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 54 | suppressed |
| Glipizide | Glipizide | 53 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 52 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 52 | 11 |
| Mirtazapine | Mirtazapine | 50 | suppressed |
| Xarelto | Rivaroxaban | 50 | suppressed |
| Mupirocin | Mupirocin | 49 | 28 |
| Dicyclomine Hcl | Dicyclomine Hcl | 48 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 47 | 22 |
| Estradiol | Estradiol | 47 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 47 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 43 | 33 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 43 | suppressed |
| Cephalexin | Cephalexin | 42 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 40 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 39 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | suppressed |
| Levofloxacin | Levofloxacin | 38 | 30 |
| Lorazepam | Lorazepam | 38 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 38 | suppressed |
| Glyburide | Glyburide | 36 | suppressed |
| Valsartan | Valsartan | 35 | suppressed |
| Linzess | Linaclotide | 34 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 34 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 34 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Spironolactone | Spironolactone | 33 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 33 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 32 | suppressed |
| Glimepiride | Glimepiride | 30 | suppressed |
| Nystatin | Nystatin | 30 | 17 |
| Amoxicillin | Amoxicillin | 29 | 20 |
| Baclofen | Baclofen | 29 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 29 | suppressed |
| Methocarbamol | Methocarbamol | 28 | suppressed |
| Sucralfate | Sucralfate | 28 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 27 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 26 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 26 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Premarin | Estrogens, Conjugated | 25 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Ibu | Ibuprofen | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Finasteride | Finasteride | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 22 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 15 |
| Tradjenta | Linagliptin | 20 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 19 | suppressed |
| Leflunomide | Leflunomide | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Mesalamine Er | Mesalamine | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 18 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Synthroid | Levothyroxine Sodium | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Ramelteon | Ramelteon | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Permethrin | Permethrin | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $83.91 · 5 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA, COLLAGENASE SANTYL, SUBLOCADE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error